‘That could be a game changer’: an antiviral pill gets first test for Ebola prevention

AI justification

First-in-class antiviral trial for Ebola prevention with potential global health impact. | The trial represents a proactive public health intervention to prevent Ebola transmission, directly supporting SDG 3 (Good Health and Well-being) and UDHR Article 25 (right to health). It addresses a critical gap in outbreak response by testing a preventative measure, which could save lives and reduce suffering in vulnerable communities.